Skip to content

Goal Directed Hemodynamic Management and Renal Outcome After Major Non-cardiac Surgery

Can Goal Directed Hemodynamic Management Improve Renal Outcome After Major Non-cardiac Surgery?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01035541
Acronym
IROM
Enrollment
180
Registered
2009-12-18
Start date
2009-12-31
Completion date
Unknown
Last updated
2013-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Non-cardiac Surgery

Keywords

Major non-cardiac surgery,, hemodynamic management,, PiCCO,, acute kidney injury,, renal outcome

Brief summary

This study is designed to compare renal outcome of patients following major non-cardiac surgery with different perioperative hemodynamic managements: a goal directed hemodynamic management group (using PiCCO) and a control group.

Detailed description

Acute kidney injury (AKI) is a common complication after major surgery. Many studies showed that AKI is associated with different complications: higher mortality, renal replacement therapy and prolonged hospital stay resulting in higher health care costs. Until now just a few studies are published on prevention or therapy of AKI after major surgery. Most of these investigations are underpowered or show just marginal benefit. There are no studies published investigating the impact of goal-directed hemodynamic management on renal outcome following non-cardiac major surgery, even though hemodynamic stability seems to be of paramount importance for the kidneys. Aim of this study is to investigate the impact of a goal directed hemodynamic management on renal outcome after major non-cardiac surgery. Therefore patients will be randomized in one of two groups, the PiCCO group with goal directed hemodynamic management and the Control group, where PICCO data will be collected but will not influence hemodynamic management. In both groups the monitoring with transpulmonary thermodilution will be continued in the intensive care unit until 72 hours after surgery.

Interventions

Fluid and vasopressor management according to PiCCO measruements

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective major non-cardiac surgery lasting more than 3 hours with a following intensive care unit stay for more than 3 days: * gastrectomy * pancreas surgery * small bowel surgery * esophageal surgery * Age ≥ 18 years * ASA classification I to III * Written informed consent

Exclusion criteria

* Need for dialysis * Contraindications for an arterial line in the femoral artery: * stents * bypasses * severe peripheral artery occlusive disease * ASA classification IV to V * Pregnant Woman

Design outcomes

Primary

MeasureTime frame
maximum change in serum creatinine within 3 daysStart of anesthesia until third postoperative day (72 hours)

Secondary

MeasureTime frameDescription
incidence of AKI according to the RIFLE criteria, need for dialysis, pulmonal complications, rate of anastomotic insufficiency, sepsis, reoperation1 yearAll points are additionnally registered one year after the operation via telephone-questionnaire of the patient and his general practitioner

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026